Trials / Completed
CompletedNCT01144598
Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
Time to DMARD Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 356 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to measure time delay from onset of symptoms to diagnosis and time to disease-modifying anti-rheumatic drug treatments in Turkish patients with rheumatoid arthritis. The investigators will also evaluate actual work limitation status of patients and impact of demographic and clinical factors on work limitations in rheumatoid arthritis patients.
Detailed description
This post marketing observational study will be conducted in cross-sectional, non-interventional, multi-center format in Turkey. As this is a post marketing observational study, Abbott is not involved in the product supply since the drug is being used according to the approved marketing label and is to be prescribed by the physician under usual and customary practice of physician prescription. Subjects will be recruited from rheumatology outpatient clinics of university hospitals and/or private offices. Patients diagnosed with rheumatoid arthritis who had received at least one disease-modifying anti-rheumatic drug, who are already employed at a paid work and able to provide disease history data will be included. Patient data will be collected with a single visit. During the single visit, all required demographic and clinical data will be recorded on the case report forms by the investigators and every subject will be asked to fill out the Work Productivity and Activity Impairment questionnaire and the Health Assessment Questionnaire - Disability Index.
Conditions
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2010-06-15
- Last updated
- 2012-10-02
- Results posted
- 2012-09-19
Locations
21 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01144598. Inclusion in this directory is not an endorsement.